These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11591293)

  • 1. [Cholesterol and tobacco: classics that withstand the passing of time].
    Ordovas JM
    Rev Esp Cardiol; 2001 Oct; 54(10):1143-5. PubMed ID: 11591293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Did we need to show, also in Spain, that cholesterolemia and tobacco are cardiovascular risk factors?].
    Rodríguez Artalejo F; Banegas Banegas JR
    Rev Esp Cardiol; 2001 Oct; 54(10):1141-2. PubMed ID: 11591292
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we eliminate inequalities in coronary disease? Absolutely.
    Tobias M; Rodgers A
    Lancet; 2008 Nov; 372(9650):1612-3. PubMed ID: 18994649
    [No Abstract]   [Full Text] [Related]  

  • 4. Smoking plus hypercholesterolemia and coronary risk.
    Perkins KA
    Am Heart J; 1987 Dec; 114(6):1527-8. PubMed ID: 3687709
    [No Abstract]   [Full Text] [Related]  

  • 5. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 6. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia.
    Niemiec P; Zak I; Wita K
    Coron Artery Dis; 2007 Aug; 18(5):339-46. PubMed ID: 17627182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The biological bases for prevention].
    Paoletti R; Poli A
    G Ital Cardiol; 1989 Sep; 19(9):763-9; discussion 778-86. PubMed ID: 2612822
    [No Abstract]   [Full Text] [Related]  

  • 8. [Coronary cardiopathy. The epidemiological and preventive aspects].
    Guimarães A
    Arq Bras Cardiol; 1992 Jul; 59(1):5-11. PubMed ID: 1341147
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors of coronary heart disease--their genesis and pediatric implications.
    Mitchell SC; Jesse MJ
    Am J Cardiol; 1973 May; 31(5):588-90. PubMed ID: 4698127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibilities and strategies for prevention of ischemic heart disease. Risk factors, trials, mass and individual strategies].
    Menotti A
    G Ital Cardiol; 1989 Sep; 19(9):770-7; discussion 778-86. PubMed ID: 2612823
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary heart disease in women. The high prevalance of coronary risk factors and the importance of prevention.
    Wenger NK
    J Med Assoc Ga; 1995 Sep; 84(7):323-8. PubMed ID: 7561540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men].
    Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP
    Sov Med; 1990; (12):57-9. PubMed ID: 2151491
    [No Abstract]   [Full Text] [Related]  

  • 13. The cholesterol non-consensus. Methodological difficulties in the interpretation of epidemiological studies.
    Berger M
    Bibl Nutr Dieta; 1992; (49):125-30. PubMed ID: 1497592
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated cholesterol levels. How to individualize treatment.
    Potts JF; Setness PA
    Postgrad Med; 1990 Sep; 88(3):233-9. PubMed ID: 2399202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime risk of developing coronary heart disease.
    Ulrich S; Hingorani AD; Martin J; Vallance P
    Lancet; 1999 Mar; 353(9156):925. PubMed ID: 10094006
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk.
    Malenka DJ; Baron JA
    Arch Intern Med; 1988 Oct; 148(10):2247-52. PubMed ID: 3178382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive measures for practically healthy men of working age].
    Fomina RF; Kozlov ID; Avramenko TV; Apanasevich VV
    Sov Zdravookhr; 1991; (8):44-7. PubMed ID: 1835803
    [No Abstract]   [Full Text] [Related]  

  • 18. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
    Zweig S
    J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble adhesion molecules and coronary heart disease.
    Cappuccio FP; Miller MA
    Lancet; 2002 Feb; 359(9305):526-7. PubMed ID: 11853826
    [No Abstract]   [Full Text] [Related]  

  • 20. Total mortality in cardiovascular risk factor intervention trials.
    Faergeman O
    Scand J Clin Lab Invest Suppl; 1990; 199():7-13. PubMed ID: 2191421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.